Phase II study ofcis-diammine(glycolato)platinum, 254-S, in patients with advanced germ-cell testicular cancer, prostatic cancer, and transitional-cell carcinoma of the urinary tract

@article{Akaza2004PhaseIS,
  title={Phase II study ofcis-diammine(glycolato)platinum, 254-S, in patients with advanced germ-cell testicular cancer, prostatic cancer, and transitional-cell carcinoma of the urinary tract},
  author={Hideyuki Akaza and Masaki Togashi and Yasunori Nishio and Tsuneharu Miki and Toshihiko Kotake and Y Matsumura and Osamu Yoshida and Yoshio Aso},
  journal={Cancer Chemotherapy and Pharmacology},
  year={2004},
  volume={31},
  pages={187-192}
}
A multicenter cooperative study was conducted to evaluate the clinical efficacy and safety ofcis-diammine(glycolato)platinum (254-S), a second-generation anticancer platinum complex, in the treatment of genitourinary cancers. 254-S was given i. v. at 100 mg/m2 at 4-week intervals. As a result, 2 complete responses (CRs) and 8 partial responses (PRs) were… CONTINUE READING